Clinical Trial Update: Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients [Phase 2]

View source ↗

Summary

Phase 2, topical, double-blind, randomized, placebo-controlled trial in psoriasis vulgaris has completed, sponsored by Delenex Therapeutics AG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Snippet

Sponsor: Delenex Therapeutics AG | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED